Introduction. Depressive disorders are one of the most common psychiatric disorders. Recognition of signs of mental health disorders is not always easy, hence the availability of simple and accurate tools for assessing them is very important in the practice of primary care. Objective. The aim of the study is to assess the theoretical accuracy and reliability of the Patient Health Questionnaire-9 (PHQ-9) in Polish conditions, when applied to general population studies for adults aged between 35-64. Materials and method. The study comprised a population of 4,040 people. Women constituted 59% of the research population and people living in the countryside 65%. The average age of participants was 53.45 ± 7.05 years. According to PHQ-9, 727 people (18.0%) had moderate, moderate to severe or severe depression. PHQ-9 showed a significant positive internal cohesion (Cronbach's alpha = 0.77), and factor charges oscillated between 0.43-0.63, and the R 2 coefficients of determination were in the range of 0.21-0.40. Conclusions. The Polish version of PHQ-9 is a valid tool for diagnosing depression in the general population aged 35-64. Good psychometric properties and compactness make the PHQ-9 a useful clinical and research tool.
INTRODUCTION
Mental health disorders are a significant epidemiological and social issue. Depressive disorders are one of the most common mental disorders. Depression is a particular type of mood, emotion and activity disorder including lowered mood, psychomotor activity, disorders of daily routine, somatic symptoms, thinking disorders and complex activity disorders [1] . According to the criteria of the World Health Organization (ICD-10), an episode of depression is characterized by the presence of specific symptoms persisting for at least two weeks [2] .
Depression has an indisputable, negative impact on all spheres of human life -from the emotional sphere, through physical efficiency, cognitive functions, and ending with social relations. It also constitutes an important risk factor for other diseases [3] .
In Poland, the first broad epidemiological study of psychiatric disorders, called EZOP according to the WHO methodology, was conducted in 2010-2011 on a representative group of adults (n = 10,081) aged 18-64. The research results indicate that mood disorder rate in the respondents was 3.5% in total, including an up to 3% depression rate [4] . According to the cited study, 766 thousand people have experienced a depressive episode in their lifetime.
The study of the prevalence of depressive disorders according to ICD-10 criteria among Primary Healthcare Units (pol. "POZ") patients in Poland, carried out in 2007, demonstrated that the criterion of depression was met by 23% of those examined [5] .
Multifactorial etiology of depression and the "masked" nature of symptoms in the clinical picture generate diagnostic problems, hindering early diagnosis and the introduction of appropriate treatment. In the national system of primary healthcare there is a lack of screening tests for the general population which would give the opportunity for a quick and early assessment of these disorders. Due to untreated depression the risk of suicides and deaths increases. Furthermore, untreated depression results in the development of somatic diseases, on the other hand somatic diseases contribute to the development of depression [6] .
In an initial diagnosis among the general population, diagnostic depression screening tools become desired. Nationally and worldwide, the most commonly implemented tools include: the Beck Depression Inventory (BDI) [7] , the Patient Health Questionnaire -9 (PHQ-9) [8] , the Hospital Anxiety and Depression Scale (HADS) [9] , and the Geriatric Depression Scale Short Form (GDS-SF) [10] . The aforementioned diagnostic tools were developed in English and then translated into other languages. However, their translations are often implemented without validation [11] .
The diagnosis of mental health disorders is arduous. The Patient Health Questionnaire-9 (PHQ-9) is a concise diagnostic instrument for screening, diagnosing depression used by healthcare professionals. The Patient Health Questionnaire-9 (PHQ-9) is a part of a larger tool kit: the Patient Health Questionnaire [8] . The questionnaire was developed based on the depression diagnostic criteria taken from the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). To date, these criteria have not undergone any significant changes in the DSM-V [12] . The 9-question depression scale items correspond to the particular symptoms of depression included in the DSM-IV and DSM-V diagnostic criteria.
In the Polish language version, the PHQ-9 instrument was made available by Pfizer Inc. at the internet address http:// www.phqscreeners.com. Easy access to the Polish version of the tool may have resulted in its application in empirical practice without checking its psychometric properties.
Currently, available Polish research by Tomaszewski, Zarychta, Bieńkowska et al. [13] has confirmed the suitable psychometric properties of the PHQ-9 instrument in the Polish language version, and recommend the questionnaire as a useful depression screening instrument among hospitalized elderly people (n = 105; mean age = 73.4; SD = 7.9 years). In 2016, the results of psychometric evaluation of the Polish version of the PHQ-9 scale were published for the group of people aged 18-60 (n = 99; mean age = 41; SD = 12. [14] .
In Polish literature, however, the psychometric evaluation of the PHQ-9 tool is still missing in relation to the general population of adults in order to check its theoretical accuracy, reliability and sensitivity to recognize the signs of depressive disorders without specific features that increase the risk of depression, e.g. geriatric age or burden associated with hospitalization due to illness.
OBJECTIVE
The purpose of the research is to assess the validity and the reliability of the PHQ-9 scale in Polish conditions in general population studies in relation to adults aged 35-64.
MATERIALS AND METHOD
The assessment of the accuracy and reliability of the PHQ-9 scale was carried out based on a cross-sectional study in 2015-2016 among 4,040 residents of Janów District (pol. "Powiat") aged 35-64. The tests were carried out as part of the project entitled "Weź sobie zdrowie do serca -program profilaktyki i promocji zdrowia w zakresie chorób układu krążenia w powiecie janowskim" ("Follow Your Heart" -programme concerning the awareness of cardiovascular diseases in the Janów District") financed by the Norwegian Financial Mechanism 2009-2014 under the PL Program 13 "Limiting social inequities in health" and the State budget. 47,500 people lived in the Janów District in the period subjected to analysis. There were 18,827 residents in the group aged between 35-64 years (data provided by the Central Statistical Office (GUS), BDL for 2014). There were 4,040 people from the selected age group included in the study, which accounted for 21.45% of this part of the population.
Patient Health Questionnaire -PHQ-9. The Polish version of PHQ-9, made available by Pfizer Inc. at the internet address http://www.phqscreeners.com was utilized for the study.
PHQ-9 is a questionnaire consisting of 9 basic questions and one additional question. The answer to each question is scored on a scale from 0-3, depending on the frequency of a given symptom in the last 2 weeks (3 points indicate the most frequent occurrence of the symptom). The diagnosis includes following severity stages: 0-4 none, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, 20-27 severe depression [15] .
Statistical analysis. Data was expressed as mean and standard deviation (SD). The Shapiro Wilk test was used to assess conformity with a normal distribution. The relationship between the examined variables was determined using a non-parametric chi-square test.
To confirm the 1-factor structure of the PHQ-9 tool, a confirmatory factor analysis (CFA)was performed with use of the AMOS 20.0 software suite. The Cronbach's alpha internal reliability estimate was used to assess the reliability of the scale. 
RESULTS
Characteristics of the examined group. The examined group (n = 4,040) consisted mainly of women (59%) and people living in rural areas (65%). The average age of respondents was 53.45 ± 7.05 years. The respondents most often had vocational (38%) and secondary (32%) education. Over 86.7% of respondents were married (Tab. 1).
Results of depressive disorders by PHQ-9 in the study group. It was observed that in the study group, according to the PHQ-9 test, 18.0% of the respondents had moderate, moderate-to-severe or severe depression. Men (33.8%) were more likely to have a test in the limits of the normal value than women (27.7%). Among women, there was a significantly higher, statistically significant percentage of participants with moderate depression (p <0.001) (Tab. 2). The chi-square test results were statistically significant; nonetheless, the test result was strongly dependent on the sample size, number of variables, number of free parameters, or deviations from the normality of the distribution. Other adjustment measures were referenced, and their values were acceptable, indicating appropriateness of the empirical data to the model.
The matching indicators demonstrate that the model fits well with the data, which denotes the factor relevance of the construct (the construct is one-dimensional).
The internal compatibility of the 9-point scale is a = 0.77 and is satisfactory from the point of view of empirical research (Cronbach's alpha). The removal of any item does not improve the overall compatibility of the internal scale. The skewness and kurtosis of item 9 proved to be the sole issue. 
DISCUSSION
The results obtained in the study confirm that the Polish version of PHQ-9 is a tool with satisfactory psychometric properties (Cronbach's alpha = 0.77) for the group of adults aged 35 -64, which may be applicable to screening for depression in the general population of adult Poles. The Cronbach alpha value is lower than in the original study by Kroenke, Spitzer and Williams [15] , conducted in a group of 3,000 primary care patients and 3,000 people in maternity and gynecological clinics. The internal reliability of PHQ-9 was excellent, with Cronbach's alpha a = 0.89 in the PHQ Primary Care Study and a = 0.86 in the PHQ Ob-Gyn study [15] . The obtained results are slightly lower in this respect, also in comparison with the results of the Polish study in the group of hospitalized persons (n = 99) where the Cronbach's alpha for PHQ-9 was 0.88 [14] . The obtained reliability of the PHQ-9 test proved to be slightly higher than for the group of Polish seniors (n = 105), where the PHQ-9 demonstrated only good internal consistency (Cronbach's alpha coefficient = 0.7) [13] . Differences in the results of PHQ-9 reliability in various studies may stem from a greater variation in the participants in the discussed studies due to the structure of gender, age or medical conditions. This can also be observed in numerous groups and populations whose validation results are described in English literature. Research conducted in primary care in Scotland (n = 1,063) concerning the PHQ-9 instrument showed high internal consistency (Cronbach's alpha = 0.83) [16] .
In research by Wang, Bian, Zhao et al. [17] , the reliability of the Chinese version of PHQ-9 in detecting depression among the residents of that community (n = 1,045) resulted in Cronbach's alpha = 0.86. In the study of the reliability of the Arabic version of PHQ-9 in a group of students of the King Saud University in Riyadh (n = 731), the obtained Cronbach's alpha coefficient was = 0.85 [18] .
Undoubtedly, it is crucial to provide effective screening methods for population depression that are directly related to primary care systems in order that patients with depressive disorder are adequately treated. This is especially important as an effective treatment of depression, not only to reduce symptoms associated with the disease and to decrease the risk of suicide, but also to improve the functioning and offset the negative effects that depressive symptoms can have on the physical well-being of adults.
The US Preventive Services Task Force Report (USPSTF) from 2002 enumerates crucial recommendations for such a tool kit, i.e. sufficiently reliable assessment scales reported by patients with depression are readily available and useful in primary care, and such screening tests that can lead to a thorough diagnosis and treatment of depression symptoms in primary care. When considering screening tools, the Patient Health Questionnaire (PHQ-9) appeared as the first choice for the majority of primary care facilities and adult populations. This instrument can accurately identify about 80% of "actual" cases, with a positive predictive value of around 50% [19] . Physicians should be aware that such sensitivity, although acceptable for screening, does not mean that a lower result excludes the diagnosis of depression (about 1 in 5 real cases, score below the threshold), and that in the second half the "positive" result will be related to symptoms that can be attributed to other disorders [20] .
In Polish studies carried out by Kokoszka et al. [14] in a group of 99 people, the best combination of sensitivity and specificity for the PFQ-9 scale, 82% and 89% respectively, was achieved at the cut-off point of 12, which means that the mentioned sensitivity and specificity in the diagnosis of the depressive episode, the results are > 12 points on the scale. Nevertheless, the implemented validation studies have some limitations. The limitation of this study is the lack of 
assessment of relevance to other tools used to assess depression in the general population, e.g. the Beck Depression Inventory (BDI). Additionally, the study did not include assessment of the sensitivity and specificity of the scale to determine the cut-off threshold guaranteeing the greatest sensitivity and specificity for the diagnosis of depression in the general population. However, care has been taken to ensure that the study covers a large and diversified group of people, including those who are completely healthy, people with risk factors and respondents diagnosed with chronic diseases, among whom the occurrence of depressive symptoms is higher than in the general population. It is undoubtedly a larger group (n = 4,040) and differs from the respondents in validation studies of the Polish language version of PHQ-9 for older people, which included 105 people hospitalized in the Department of Internal Medicine and Geriatrics [12] [14] .
CONCLUSIONS
The Polish version of PHQ-9 is a good tool for diagnosing depressive disorders in a specific general population 
